These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 2422605

  • 21. [Clinical evaluation of a prostate-specific antigen as a serum marker of prostatic cancer].
    Park YC, Kiwamoto H, Nishioka T, Tsujihashi H, Mitsubayashi S, Matsuura T, Akiyama T, Kurita T, Miyamoto T.
    Hinyokika Kiyo; 1987 Jun; 33(6):883-8. PubMed ID: 2445188
    [Abstract] [Full Text] [Related]

  • 22. Tumour markers in monitoring the treatment of advanced prostate cancer.
    Cooper EH, Armitage TG.
    Prog Clin Biol Res; 1990 Jun; 359():65-72; discussion 73-4. PubMed ID: 1704634
    [No Abstract] [Full Text] [Related]

  • 23. Screening for adenocarcinoma of the prostate.
    Miles BJ.
    Henry Ford Hosp Med J; 1989 Jun; 37(1):5-7. PubMed ID: 2475458
    [No Abstract] [Full Text] [Related]

  • 24. Use of gonadotropin-releasing hormone analogue in advanced prostatic cancer: 3 years clinical experience.
    Matzkin H, Greenstein A, Kaver I, Braf Z.
    Isr J Med Sci; 1989 Jul; 25(7):388-92. PubMed ID: 2474522
    [Abstract] [Full Text] [Related]

  • 25. [The diagnostic value of serum acid phosphatases in carcinoma of the prostate (author's transl)].
    Braun JS, Habig H, Crüsemann D.
    Urologe A; 1974 Sep; 13(5):236-41. PubMed ID: 4138057
    [No Abstract] [Full Text] [Related]

  • 26. Immunologic markers and the diagnosis of prostatic cancer.
    Ban Y, Wang MC, Chu TM.
    Urol Clin North Am; 1984 May; 11(2):269-76. PubMed ID: 6203206
    [Abstract] [Full Text] [Related]

  • 27. The role of prostatic acid phosphatase in the investigation and treatment of adenocarcinoma of the prostate.
    Bruce AW, Mahan DE.
    Ann N Y Acad Sci; 1982 May; 390():110-21. PubMed ID: 6953923
    [No Abstract] [Full Text] [Related]

  • 28. [Role of gamma-seminoprotein (gamma-SM) and prostatic acid phosphatase (PAP) as tumor markers of prostatic cancer].
    Watanabe M, Kitamura Y, Komatsubara S, Sakata Y.
    Hinyokika Kiyo; 1988 Dec; 34(12):2135-41. PubMed ID: 2467542
    [Abstract] [Full Text] [Related]

  • 29. [Clinical relevance of radioimmunologic determination of prostate specific antigen in prostate cancer].
    Fornara P, Sturm W, Fabricius PG, Schmiedt E.
    Urologe A; 1987 May; 26(3):158-61. PubMed ID: 2440170
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Minimum prostate-specific antigen (PSA) level diagnostic of prostate cancer.
    Yesner R, Kelly LJ, Chan YK.
    Conn Med; 1996 Jul; 60(7):399-404. PubMed ID: 8758658
    [Abstract] [Full Text] [Related]

  • 34. [Role of prostate-specific antigen in prostatic carcinoma. Validity of an integrated methodologic approach and morpho-biological correlations].
    Tomasino RM, Lo Bianco A, Cacciatore M, Pavone C, Carreca I, Morello V, Salvato M, Florena AM, Pavone-Macaluso M.
    Pathologica; 1989 Jul; 81(1072):109-26. PubMed ID: 2475847
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Prostate specific antigen in serum of the patients with prostatic cancer].
    Akimoto S, Akakura K, Fuse H, Shimazaki J.
    Hinyokika Kiyo; 1988 Apr; 34(4):636-42. PubMed ID: 2456678
    [Abstract] [Full Text] [Related]

  • 37. [The clinical and prognostic value of inversion of the PSA/PAP ratio in prostatic cancer].
    Morote Robles J, Lorente JA, Reig C, López Pacios MA, de Torres JA, Soler Roselló A.
    Actas Urol Esp; 1994 May; 18(5):559-61. PubMed ID: 7521563
    [Abstract] [Full Text] [Related]

  • 38. Critical-laboratoristic correlation of the diagnostic importance of prostate specific antigen compared with prostatic acid phosphatase and carcinoembryonic antigen in the prostatic cancer.
    Milani M, Tacconi R, Marsili G, Trognoni A, Centioni G, Leoni T, Fumarola A.
    Quad Sclavo Diagn; 1986 Dec; 22(4):428-32. PubMed ID: 2445000
    [No Abstract] [Full Text] [Related]

  • 39. [Anatomoclinical and biologic correlations in prostatic pathology. Apropos of 150 case reports].
    Amiel J, Chevallier D, Peyrottes A, Benoliel J, Toubol J.
    Ann Urol (Paris); 1989 Dec; 23(6):528-30. PubMed ID: 2482700
    [Abstract] [Full Text] [Related]

  • 40. [A case of prostate cancer with invasion to the middle ureter].
    Matsuo T, Hayashida Y, Takehara K, Tsuda S, Furukawa M, Iwasaki S.
    Hinyokika Kiyo; 2004 Jan; 50(1):61-3. PubMed ID: 15032020
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.